Other Species / Isoforms
  BUD13 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S8
MAAAPPLSKAEYLKR
0 1
BUD13 (human) MAAAPPLSKAEYLKR S8
BUD13 iso2 (human) MAAAPPLSKAEYLKR S8
BUD13 (mouse) MAAAPPLtKAEYLKR T8-p
BUD13 (rat) MAAAPPLSKAEYLKR S8
S18-p
EYLKRYLsGADAGVD
Upstream
0 12
Kinase, in vitro:
  • Chk1 (human)
BUD13 (human) EYLKRYLsGADAGVD S18-p
BUD13 iso2 (human) EYLKRYLSGADAGVD S18
BUD13 (mouse) EYLKRYLSGTDAGLE S18
BUD13 (rat) EYLKRYLSGTDAGLE S18
R26-m1
GADAGVDrGsEsGRK
0 1
BUD13 (human) GADAGVDrGsEsGRK R26-m1
BUD13 iso2 (human) GADAGVDRGSESGRK R26
BUD13 (mouse) GTDAGLEGGPEAGRK G26
BUD13 (rat) GTDAGLEGGPESGRK G26
S28-p
DAGVDrGsEsGRKRR
0 6
BUD13 (human) DAGVDrGsEsGRKRR S28-p
BUD13 iso2 (human) DAGVDRGSESGRKRR S28
BUD13 (mouse) DAGLEGGPEAGRKRR P28
BUD13 (rat) DAGLEGGPESGRKRR P28
S30-p
GVDrGsEsGRKRRKK
0 1
BUD13 (human) GVDrGsEsGRKRRKK S30-p
BUD13 iso2 (human) GVDRGSESGRKRRKK S30
BUD13 (mouse) GLEGGPEAGRKRRKK A30
BUD13 (rat) GLEGGPESGRKRRKK S30
K40-ac
KRRKKRPkPGGAGGk
0 1
BUD13 (human) KRRKKRPkPGGAGGk K40-ac
BUD13 iso2 (human) KRRKKRPKPGGAGGK K40
BUD13 (mouse) KRRKKRPKPGGAGGK K40
BUD13 (rat) KRRKKRPKPGGAGGK K40
K47-ac
kPGGAGGkGMRIVDD
0 7
BUD13 (human) kPGGAGGkGMRIVDD K47-ac
BUD13 iso2 (human) KPGGAGGKGMRIVDD K47
BUD13 (mouse) KPGGAGGKGMRIVDD K47
BUD13 (rat) KPGGAGGKGMRIVDD K47
S57-p
RIVDDDVsWTAISTT
0 1
BUD13 (human) RIVDDDVsWTAISTT S57-p
BUD13 iso2 (human) RIVDDDVSWTAISTT S57
BUD13 (mouse) RIVDDDVGWAAISTA G57
BUD13 (rat) RIVDDDVGWAAISTD G57
K65-sm
WTAISTTkLEKEEEE
0 1
BUD13 (human) WTAISTTkLEKEEEE K65-sm
BUD13 iso2 (human) WTAISTTKLEKEEEE K65
BUD13 (mouse) WAAISTAKPEKEEEE K65
BUD13 (rat) WAAISTDKLEKEEEE K65
K104-ub
FRSSAKWkLLGGHNE
0 1
BUD13 (human) FRSSAKWkLLGGHNE K104-ub
BUD13 iso2 (human) FRSSAKWKLLGGHNE K104
BUD13 (mouse) FRSSAKWKLLGGHGE K103
BUD13 (rat) FRSSTKWKLLGGYSE K103
T123-p
NRHFRHDtPDssPRR
0 49
BUD13 (human) NRHFRHDtPDssPRR T123-p
BUD13 iso2 (human) NRHFRHDTPDSSPRR T123
BUD13 (mouse) DGHFHHDDQDssPPR D118
BUD13 (rat) DGHFHNDDQDPSPPR D118
S126-p
FRHDtPDssPRRVRH
0 18
BUD13 (human) FRHDtPDssPRRVRH S126-p
BUD13 iso2 (human) FRHDTPDSSPRRVRH S126
BUD13 (mouse) FHHDDQDssPPRRVR S121-p
BUD13 (rat) FHNDDQDPSPPRKAR P121
S127-p
RHDtPDssPRRVRHG
0 32
BUD13 (human) RHDtPDssPRRVRHG S127-p
BUD13 iso2 (human) RHDTPDSSPRRVRHG S127
BUD13 (mouse) HHDDQDssPPRRVRH S122-p
BUD13 (rat) HNDDQDPSPPRKARH S122
T135-p
PRRVRHGtPDPsPRK
Upstream
0 73
Treatment
  • metformin
BUD13 (human) PRRVRHGtPDPsPRK T135-p
BUD13 iso2 (human) PRRVRHGTPDPSPRK T135
BUD13 (mouse) PRRVRHDtPDtsPPR T131-p
BUD13 (rat) PRKARHDtPDAsPPR T131-p
P138
VRHGtPDPsPRKDRH
0 4
BUD13 (human) VRHGtPDPsPRKDRH P138
BUD13 iso2 (human) VRHGTPDPSPRKDRH P138
BUD13 (mouse) VRHDtPDtsPPRKAR T134-p
BUD13 (rat) ARHDtPDAsPPRRVR A134
S139-p
RHGtPDPsPRKDRHD
Upstream
0 66
Treatment
  • metformin
BUD13 (human) RHGtPDPsPRKDRHD S139-p
BUD13 iso2 (human) RHGTPDPSPRKDRHD S139
BUD13 (mouse) RHDtPDtsPPRKARH S135-p
BUD13 (rat) RHDtPDAsPPRRVRH S135-p
T147-p
PRKDRHDtPDPsPRR
Upstream
0 87
Treatment
  • dasatinib
  • metformin
BUD13 (human) PRKDRHDtPDPsPRR T147-p
BUD13 iso2 (human) PRKDRHDTPDPSPRR T147
BUD13 (mouse) PRKARHDtPDPsPPR T144-p
BUD13 (rat) PRRVRHGtPEPsPPR T144-p
S151-p
RHDtPDPsPRRARHD
Upstream
0 87
Treatment
  • dasatinib
  • metformin
BUD13 (human) RHDtPDPsPRRARHD S151-p
BUD13 iso2 (human) RHDTPDPSPRRARHD S151
BUD13 (mouse) RHDtPDPsPPRKARH S148-p
BUD13 (rat) RHGtPEPsPPRRVRH S148-p
T159-p
PRRARHDtPDPsPLR
Upstream
Downstream
1 100
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
Kinase, in vitro:
  • RSK3 (human)
Putative in vivo kinases:
  • RSK3 (human)
Treatment
  • dasatinib
  • nocodazole
BUD13 (human) PRRARHDtPDPsPLR T159-p
BUD13 iso2 (human) PRRARHDTPDPSPLR T159
BUD13 (mouse) PRKARHDtPDtsPPR T157-p
BUD13 (rat) PRRVRHDtPDPsPPR T157-p
P162
ARHDtPDPsPLRGAR
0 4
BUD13 (human) ARHDtPDPsPLRGAR P162
BUD13 iso2 (human) ARHDTPDPSPLRGAR P162
BUD13 (mouse) ARHDtPDtsPPRKAR T160-p
BUD13 (rat) VRHDtPDPsPPRRVR P160
S163-p
RHDtPDPsPLRGARH
Upstream
0 96
Treatment
  • dasatinib
  • nocodazole
BUD13 (human) RHDtPDPsPLRGARH S163-p
BUD13 iso2 (human) RHDTPDPSPLRGARH S163
BUD13 (mouse) RHDtPDtsPPRKARH S161-p
BUD13 (rat) RHDtPDPsPPRRVRH S161-p
S172-p
LRGARHDsDtsPPRR
0 64
BUD13 (human) LRGARHDsDtsPPRR S172-p
BUD13 iso2 (human) LRGARHDSDTSPPRR S172
BUD13 (mouse) PRKARHDtPDPsPPR T170-p
BUD13 (rat) PRRVRHDsPDPsPTR S170-p
T174-p
GARHDsDtsPPRRIR
0 6
BUD13 (human) GARHDsDtsPPRRIR T174-p
BUD13 iso2 (human) GARHDSDTSPPRRIR T174
BUD13 (mouse) ARHDtPDPsPPRKAR P173
BUD13 (rat) VRHDsPDPsPTRRGH P173
S175-p
ARHDsDtsPPRRIRH
0 31
BUD13 (human) ARHDsDtsPPRRIRH S175-p
BUD13 iso2 (human) ARHDSDTSPPRRIRH S175
BUD13 (mouse) RHDtPDPsPPRKARH S174-p
BUD13 (rat) RHDsPDPsPTRRGHD S174-p
S184-p
PRRIRHDssDtsPPR
Upstream
0 45
Treatment
  • ionizing_radiation
BUD13 (human) PRRIRHDssDtsPPR S184-p
BUD13 iso2 (human) PRRIRHDSSDTSPPR S184
BUD13 (mouse) PRKARHDtPDPsPPR T183-p
BUD13 (rat) PTRRGHDsPDPsPTR S182-p
S185-p
RRIRHDssDtsPPRR
Upstream
0 16
Treatment
  • ionizing_radiation
BUD13 (human) RRIRHDssDtsPPRR S185-p
BUD13 iso2 (human) RRIRHDSSDTSPPRR S185
BUD13 (mouse) RKARHDtPDPsPPRR P184
BUD13 (rat) TRRGHDsPDPsPTRR P183
T187-p
IRHDssDtsPPRRAR
0 2
BUD13 (human) IRHDssDtsPPRRAR T187-p
BUD13 iso2 (human) IRHDSSDTSPPRRAR T187
BUD13 (mouse) ARHDtPDPsPPRRVR P186
BUD13 (rat) RGHDsPDPsPTRRVH P185
S188-p
RHDssDtsPPRRARH
0 38
BUD13 (human) RHDssDtsPPRRARH S188-p
BUD13 iso2 (human) RHDSSDTSPPRRARH S188
BUD13 (mouse) RHDtPDPsPPRRVRH S187-p
BUD13 (rat) GHDsPDPsPTRRVHH S186-p
S197-p
PRRARHDsPDPsPPR
Upstream
0 118
Treatment
  • dasatinib
  • ionizing_radiation
  • metformin
  • nocodazole
BUD13 (human) PRRARHDsPDPsPPR S197-p
BUD13 iso2 (human) PRRARHDSPDPSPPR S197
BUD13 (mouse) PRRVRHDtPDLsPPR T196-p
BUD13 (rat) TRRVHHDsPDPsPPR S195-p
S201-p
RHDsPDPsPPRRPQH
Upstream
0 113
Treatment
  • dasatinib
  • metformin
  • nocodazole
BUD13 (human) RHDsPDPsPPRRPQH S201-p
BUD13 iso2 (human) RHDSPDPSPPRRPQH S201
BUD13 (mouse) RHDtPDLsPPRRVRH S200-p
BUD13 (rat) HHDsPDPsPPRRVRH S199-p
S210-p
PRRPQHNssGAsPRR
0 34
BUD13 (human) PRRPQHNssGAsPRR S210-p
BUD13 iso2 (human) PRRPQHNSSGDCQKA S210
BUD13 (mouse) PRRVRHDtPDLsPPR T209-p
BUD13 (rat) PRRVRHDtPDPsPPR T208-p
S211-p
RRPQHNssGAsPRRV
0 1
BUD13 (human) RRPQHNssGAsPRRV S211-p
BUD13 iso2 (human) RRPQHNSSGDCQKAT S211
BUD13 (mouse) RRVRHDtPDLsPPRR P210
BUD13 (rat) RRVRHDtPDPsPPRR P209
S214-p
QHNssGAsPRRVRHD
0 44
BUD13 (human) QHNssGAsPRRVRHD S214-p
BUD13 iso2 (human) gap -
BUD13 (mouse) RHDtPDLsPPRRVRH S213-p
BUD13 (rat) RHDtPDPsPPRRVRH S212-p
S222-p
PRRVRHDsPDPsPPR
Upstream
0 118
Treatment
  • dasatinib
  • nocodazole
BUD13 (human) PRRVRHDsPDPsPPR S222-p
BUD13 iso2 (human) gap -
BUD13 (mouse) PRRVRHDtPDPsPPR T222-p
BUD13 (rat) PRRVRHDtPDPsPPR T221-p
S226-p
RHDsPDPsPPRRARH
Upstream
0 117
Treatment
  • dasatinib
  • nocodazole
BUD13 (human) RHDsPDPsPPRRARH S226-p
BUD13 iso2 (human) gap -
BUD13 (mouse) RHDtPDPsPPRRVRH S226-p
BUD13 (rat) RHDtPDPsPPRRVRH S225-p
-
gap
0 1
BUD13 (human) gap -
BUD13 iso2 (human) gap -
BUD13 (mouse) PRRVRHDLDAsPPRK L235
BUD13 (rat) PRRVRHDsDAsPPRR S234-p
-
gap
0 26
BUD13 (human) gap -
BUD13 iso2 (human) gap -
BUD13 (mouse) VRHDLDAsPPRKSHR S238-p
BUD13 (rat) VRHDsDAsPPRRSHR S237-p
-
gap
0 1
BUD13 (human) gap -
BUD13 iso2 (human) gap -
BUD13 (mouse) PRKSHRNssAVsPRR S247-p
BUD13 (rat) PRRSHRNSSAVSPKR S246
-
gap
0 1
BUD13 (human) gap -
BUD13 iso2 (human) gap -
BUD13 (mouse) RKSHRNssAVsPRRG S248-p
BUD13 (rat) RRSHRNSSAVSPKRG S247
-
gap
0 6
BUD13 (human) gap -
BUD13 iso2 (human) gap -
BUD13 (mouse) HRNssAVsPRRGHHG S251-p
BUD13 (rat) HRNSSAVSPKRGHHG S250
S235-p
PRRARHGssDIssPR
Upstream
1 60
Kinase, in vitro:
  • RSK3 (human)
Putative in vivo kinases:
  • RSK3 (human)
Treatment
  • nocodazole
BUD13 (human) PRRARHGssDIssPR S235-p
BUD13 iso2 (human) gap -
BUD13 (mouse) PRRGHHGsLGtssPR S259-p
BUD13 (rat) PKRGHHGSSGTsSPR S258
S236-p
RRARHGssDIssPRR
0 14
BUD13 (human) RRARHGssDIssPRR S236-p
BUD13 iso2 (human) gap -
BUD13 (mouse) RRGHHGsLGtssPRQ L260
BUD13 (rat) KRGHHGSSGTsSPRQ S259
I238
ARHGssDIssPRRVH
0 3
BUD13 (human) ARHGssDIssPRRVH I238
BUD13 iso2 (human) gap -
BUD13 (mouse) GHHGsLGtssPRQtH T262-p
BUD13 (rat) GHHGSSGTsSPRQAH T261
S239-p
RHGssDIssPRRVHN
Upstream
0 13
Treatment
  • nocodazole
BUD13 (human) RHGssDIssPRRVHN S239-p
BUD13 iso2 (human) gap -
BUD13 (mouse) HHGsLGtssPRQtHN S263-p
BUD13 (rat) HHGSSGTsSPRQAHN S262-p
S240-p
HGssDIssPRRVHNN
Upstream
0 43
Treatment
  • nocodazole
BUD13 (human) HGssDIssPRRVHNN S240-p
BUD13 iso2 (human) gap -
BUD13 (mouse) HGsLGtssPRQtHNH S264-p
BUD13 (rat) HGSSGTsSPRQAHNH S263
V244
DIssPRRVHNNsPDt
0 1
BUD13 (human) DIssPRRVHNNsPDt V244
BUD13 iso2 (human) gap -
BUD13 (mouse) GtssPRQtHNHsPtA T268-p
BUD13 (rat) GTsSPRQAHNHSPAA A267
S248-p
PRRVHNNsPDtSRRt
0 104
BUD13 (human) PRRVHNNsPDtSRRt S248-p
BUD13 iso2 (human) gap -
BUD13 (mouse) PRQtHNHsPtAAQHR S272-p
BUD13 (rat) PRQAHNHSPAAAQHR S271
D250
RVHNNsPDtSRRtLG
0 1
BUD13 (human) RVHNNsPDtSRRtLG D250
BUD13 iso2 (human) gap -
BUD13 (mouse) QtHNHsPtAAQHRRT T274-p
BUD13 (rat) QAHNHSPAAAQHRRT A273
T251-p
VHNNsPDtSRRtLGs
0 2
BUD13 (human) VHNNsPDtSRRtLGs T251-p
BUD13 iso2 (human) gap -
BUD13 (mouse) tHNHsPtAAQHRRTL A275
BUD13 (rat) AHNHSPAAAQHRRTL A274
T255-p
sPDtSRRtLGssDtQ
0 4
BUD13 (human) sPDtSRRtLGssDtQ T255-p
BUD13 iso2 (human) gap -
BUD13 (mouse) tAAQHRRTLDSSGTQ T281
BUD13 (rat) AAAQHRRTLDSSGAQ T280
S258-p
tSRRtLGssDtQQLR
0 4
BUD13 (human) tSRRtLGssDtQQLR S258-p
BUD13 iso2 (human) gap -
BUD13 (mouse) QHRRTLDSSGTQHLR S284
BUD13 (rat) QHRRTLDSSGAQHHR S283
S259-p
SRRtLGssDtQQLRR
0 1
BUD13 (human) SRRtLGssDtQQLRR S259-p
BUD13 iso2 (human) gap -
BUD13 (mouse) HRRTLDSSGTQHLRR S285
BUD13 (rat) HRRTLDSSGAQHHRR S284
T261-p
RtLGssDtQQLRRAR
0 1
BUD13 (human) RtLGssDtQQLRRAR T261-p
BUD13 iso2 (human) gap -
BUD13 (mouse) RTLDSSGTQHLRRAH T287
BUD13 (rat) RTLDSSGAQHHRRAR A286
S271-p
LRRARHDsPDLAPNV
Upstream
0 145
Treatment
  • dasatinib
  • LRRK2-IN-1
  • metastatic potential
  • nocodazole
BUD13 (human) LRRARHDsPDLAPNV S271-p
BUD13 iso2 (human) gap -
BUD13 (mouse) LRRAHHEsPDLELHK S297-p
BUD13 (rat) HRRARHDsPDLELPK S296-p
T279-p
PDLAPNVtysLPRTK
0 3
BUD13 (human) PDLAPNVtysLPRTK T279-p
BUD13 iso2 (human) gap -
BUD13 (mouse) gap -
BUD13 (rat) gap -
Y280-p
DLAPNVtysLPRTKS
0 6
BUD13 (human) DLAPNVtysLPRTKS Y280-p
BUD13 iso2 (human) gap -
BUD13 (mouse) gap -
BUD13 (rat) gap -
S281-p
LAPNVtysLPRTKSG
Upstream
0 7
Treatment
  • nocodazole
BUD13 (human) LAPNVtysLPRTKSG S281-p
BUD13 iso2 (human) gap -
BUD13 (mouse) HHEsPDLELHKAKSS E301
BUD13 (rat) RHDsPDLELPKAKSS E300
T298-p
PERASSKtsPHWKES
0 1
BUD13 (human) PERASSKtsPHWKES T298-p
BUD13 iso2 (human) gap -
BUD13 (mouse) AERAPSKAAsQSGLG A318
BUD13 (rat) AERPSSKTVSQSGLG T317
S299-p
ERASSKtsPHWKESG
0 5
BUD13 (human) ERASSKtsPHWKESG S299-p
BUD13 iso2 (human) gap -
BUD13 (mouse) ERAPSKAAsQSGLGP A319
BUD13 (rat) ERPSSKTVSQSGLGP V318
P300
RASSKtsPHWKESGA
0 2
BUD13 (human) RASSKtsPHWKESGA P300
BUD13 iso2 (human) gap -
BUD13 (mouse) RAPSKAAsQSGLGPS S320-p
BUD13 (rat) RPSSKTVSQSGLGPP S319
S308-p
HWKESGAsHLsFPKN
0 1
BUD13 (human) HWKESGAsHLsFPKN S308-p
BUD13 iso2 (human) gap -
BUD13 (mouse) sQSGLGPSHPSLSTN S327
BUD13 (rat) SQSGLGPPHPSLSMN P326
S311-p
ESGAsHLsFPKNSKy
0 2
BUD13 (human) ESGAsHLsFPKNSKy S311-p
BUD13 iso2 (human) gap -
BUD13 (mouse) GLGPSHPSLSTNSKy S330
BUD13 (rat) GLGPPHPSLSMNSKY S329
Y318-p
sFPKNSKyEYDPDIs
0 2
BUD13 (human) sFPKNSKyEYDPDIs Y318-p
BUD13 iso2 (human) gap -
BUD13 (mouse) SLSTNSKyEHDsDLs Y337-p
BUD13 (rat) SLSMNSKYEHDsDLs Y336
P322
NSKyEYDPDIsPPRK
0 14
BUD13 (human) NSKyEYDPDIsPPRK P322
BUD13 iso2 (human) gap -
BUD13 (mouse) NSKyEHDsDLsPPRK S341-p
BUD13 (rat) NSKYEHDsDLsPPRK S340-p
S325-p
yEYDPDIsPPRKKQA
0 61
BUD13 (human) yEYDPDIsPPRKKQA S325-p
BUD13 iso2 (human) gap -
BUD13 (mouse) yEHDsDLsPPRKRQA S344-p
BUD13 (rat) YEHDsDLsPPRKRQA S343-p
K340
KSHFGDKKQLDSKGD
0 1
BUD13 (human) KSHFGDKKQLDSKGD K340
BUD13 iso2 (human) gap -
BUD13 (mouse) KAHFEAKkQLDSKGV K359-ac
BUD13 (rat) KAHFGAKKQLDSKGV K358
T352
KGDCQKATDsDLssP
0 7
BUD13 (human) KGDCQKATDsDLssP T352
BUD13 iso2 (human) SGDCQKATDSDLSSP T218
BUD13 (mouse) KGVYQKAsDsDLsPP S371-p
BUD13 (rat) KGVCQKASDSDLsPP S370
S354-p
DCQKATDsDLssPRH
0 16
BUD13 (human) DCQKATDsDLssPRH S354-p
BUD13 iso2 (human) DCQKATDSDLSSPRH S220
BUD13 (mouse) VYQKAsDsDLsPPRK S373-p
BUD13 (rat) VCQKASDSDLsPPRK S372
S357-p
KATDsDLssPRHKQs
0 18
BUD13 (human) KATDsDLssPRHKQs S357-p
BUD13 iso2 (human) KATDSDLSSPRHKQS S223
BUD13 (mouse) KAsDsDLsPPRKKKN S376-p
BUD13 (rat) KASDSDLsPPRKNSK S375-p
S358-p
ATDsDLssPRHKQsP
Upstream
0 107
Treatment
  • antibody
BUD13 (human) ATDsDLssPRHKQsP S358-p
BUD13 iso2 (human) ATDSDLSSPRHKQSP S224
BUD13 (mouse) AsDsDLsPPRKKKNs P377
BUD13 (rat) ASDSDLsPPRKNSKS P376
S364-p
ssPRHKQsPGHQDsD
0 11
BUD13 (human) ssPRHKQsPGHQDsD S364-p
BUD13 iso2 (human) SSPRHKQSPGHQDSD S230
BUD13 (mouse) sPPRKKKNsGHQDsD N383
BUD13 (rat) sPPRKNSKSGHQDsD K382
P365
sPRHKQsPGHQDsDs
0 2
BUD13 (human) sPRHKQsPGHQDsDs P365
BUD13 iso2 (human) SPRHKQSPGHQDSDS P231
BUD13 (mouse) PPRKKKNsGHQDsDs S384-p
BUD13 (rat) PPRKNSKSGHQDsDs S383
S370-p
QsPGHQDsDsDLsPP
0 18
BUD13 (human) QsPGHQDsDsDLsPP S370-p
BUD13 iso2 (human) QSPGHQDSDSDLSPP S236
BUD13 (mouse) KNsGHQDsDsDLsPP S389-p
BUD13 (rat) SKSGHQDsDsDLsPP S388-p
S372-p
PGHQDsDsDLsPPRN
0 17
BUD13 (human) PGHQDsDsDLsPPRN S372-p
BUD13 iso2 (human) PGHQDSDSDLSPPRN S238
BUD13 (mouse) sGHQDsDsDLsPPRN S391-p
BUD13 (rat) SGHQDsDsDLsPPRN S390-p
S375-p
QDsDsDLsPPRNRPR
0 18
BUD13 (human) QDsDsDLsPPRNRPR S375-p
BUD13 iso2 (human) QDSDSDLSPPRNRPR S241
BUD13 (mouse) QDsDsDLsPPRNRPR S394-p
BUD13 (rat) QDsDsDLsPPRNRPR S393-p
S385-p
RNRPRHRssDsDLsP
0 33
BUD13 (human) RNRPRHRssDsDLsP S385-p
BUD13 iso2 (human) RNRPRHRSSDSDLSP S251
BUD13 (mouse) RNRPRRQssDsDLsP S404-p
BUD13 (rat) RNRPRRQSSDSDLSP S403
S386-p
NRPRHRssDsDLsPP
0 32
BUD13 (human) NRPRHRssDsDLsPP S386-p
BUD13 iso2 (human) NRPRHRSSDSDLSPP S252
BUD13 (mouse) NRPRRQssDsDLsPP S405-p
BUD13 (rat) NRPRRQSSDSDLSPP S404
S388-p
PRHRssDsDLsPPRR
0 35
BUD13 (human) PRHRssDsDLsPPRR S388-p
BUD13 iso2 (human) PRHRSSDSDLSPPRR S254
BUD13 (mouse) PRRQssDsDLsPPRR S407-p
BUD13 (rat) PRRQSSDSDLSPPRR S406
S391-p
RssDsDLsPPRRRQR
Upstream
0 41
Treatment
  • metformin
BUD13 (human) RssDsDLsPPRRRQR S391-p
BUD13 iso2 (human) RSSDSDLSPPRRRQR S257
BUD13 (mouse) QssDsDLsPPRRRQR S410-p
BUD13 (rat) QSSDSDLSPPRRRQR S409
T399-p
PPRRRQRtKssDsDL
0 5
BUD13 (human) PPRRRQRtKssDsDL T399-p
BUD13 iso2 (human) PPRRRQRTKSSDSDL T265
BUD13 (mouse) PPRRRQRTKSSDSDL T418
BUD13 (rat) PPRRRQRTKSSDSDL T417
S401-p
RRRQRtKssDsDLsP
0 11
BUD13 (human) RRRQRtKssDsDLsP S401-p
BUD13 iso2 (human) RRRQRTKSSDSDLSP S267
BUD13 (mouse) RRRQRTKSSDSDLsP S420
BUD13 (rat) RRRQRTKSSDSDLSP S419
S402-p
RRQRtKssDsDLsPP
0 12
BUD13 (human) RRQRtKssDsDLsPP S402-p
BUD13 iso2 (human) RRQRTKSSDSDLSPP S268
BUD13 (mouse) RRQRTKSSDSDLsPP S421
BUD13 (rat) RRQRTKSSDSDLSPS S420
S404-p
QRtKssDsDLsPPRR
0 13
BUD13 (human) QRtKssDsDLsPPRR S404-p
BUD13 iso2 (human) QRTKSSDSDLSPPRR S270
BUD13 (mouse) QRTKSSDSDLsPPRR S423
BUD13 (rat) QRTKSSDSDLSPSRR S422
S407-p
KssDsDLsPPRRSQP
0 19
BUD13 (human) KssDsDLsPPRRSQP S407-p
BUD13 iso2 (human) KSSDSDLSPPRRSQP S273
BUD13 (mouse) KSSDSDLsPPRRSPR S426-p
BUD13 (rat) KSSDSDLSPSRRSPR S425
Y423-p
GKKAAHMysGAKTGL
0 3
BUD13 (human) GKKAAHMysGAKTGL Y423-p
BUD13 iso2 (human) GKKAAHMYSGAKTGL Y289
BUD13 (mouse) GKKTAHMYSGAKTGL Y442
BUD13 (rat) GKKTPHMYSGAKTGL Y441
S424-p
KKAAHMysGAKTGLV
0 1
BUD13 (human) KKAAHMysGAKTGLV S424-p
BUD13 iso2 (human) KKAAHMYSGAKTGLV S290
BUD13 (mouse) KKTAHMYSGAKTGLV S443
BUD13 (rat) KKTPHMYSGAKTGLV S442
T433-p
AKTGLVLtDIQREQQ
0 1
BUD13 (human) AKTGLVLtDIQREQQ T433-p
BUD13 iso2 (human) AKTGLVLTDIQREQQ T299
BUD13 (mouse) GAKTGLVTDVQREHQ T451
BUD13 (rat) GAKTGLVADVQREHQ A450
Y458-p
AFEAEFQyAETVFRD
0 7
BUD13 (human) AFEAEFQyAETVFRD Y458-p
BUD13 iso2 (human) AFEAEFQYAETVFRD Y324
BUD13 (mouse) DLGAQFEFTETVFRD F476
BUD13 (rat) DLGAQFEFTETVFRD F475
Y494-p
DSERDELyAQWGkGL
0 47
BUD13 (human) DSERDELyAQWGkGL Y494-p
BUD13 iso2 (human) DSERDELYAQWGKGL Y360
BUD13 (mouse) DSERDELYAQWGKGL Y512
BUD13 (rat) DSERDELYAQWGKGL Y511
K499-ub
ELyAQWGkGLAQSRQ
0 1
BUD13 (human) ELyAQWGkGLAQSRQ K499-ub
BUD13 iso2 (human) ELYAQWGKGLAQSRQ K365
BUD13 (mouse) ELYAQWGKGLAQSRQ K517
BUD13 (rat) ELYAQWGKGLAQSRQ K516
K555
FIKKNKAKENKNKKV
0 1
BUD13 (human) FIKKNKAKENKNKKV K555
BUD13 iso2 (human) FIKKNKAKENKNKKV K421
BUD13 (mouse) FIKKNKAkENKNKKV K573-ac
BUD13 (rat) FIKKNKAKENKNKKV K572
S567-p
KKVRPRYsGPAPPPN
0 4
BUD13 (human) KKVRPRYsGPAPPPN S567-p
BUD13 iso2 (human) KKVRPRYSGPAPPPN S433
BUD13 (mouse) KKVKPRYSGPAPPPN S585
BUD13 (rat) KKVRPRYNGPAPPPN N584
Y612-p
KAVEELAyKWSVEDM
0 1
BUD13 (human) KAVEELAyKWSVEDM Y612-p
BUD13 iso2 (human) KAVEELAYKWSVEDM Y478
BUD13 (mouse) KAVEELAYKWSVEDM Y630
BUD13 (rat) KAVEELAYKWSVEDM Y629